These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33254080)

  • 21. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D; Liu X; Liu Y; Li S; Wang C
    J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease.
    Yan J; Liu XH; Han MZ; Wang YM; Sun XL; Yu N; Li T; Su B; Chen ZY
    Neurobiol Aging; 2015 Jan; 36(1):211-27. PubMed ID: 25192600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons.
    He Y; Jia K; Li L; Wang Q; Zhang S; Du J; Du H
    Biochem Biophys Res Commun; 2018 Apr; 498(4):1066-1072. PubMed ID: 29551684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.
    Fang D; Wang Y; Zhang Z; Du H; Yan S; Sun Q; Zhong C; Wu L; Vangavaragu JR; Yan S; Hu G; Guo L; Rabinowitz M; Glaser E; Arancio O; Sosunov AA; McKhann GM; Chen JX; Yan SS
    Hum Mol Genet; 2015 Sep; 24(18):5198-210. PubMed ID: 26123488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
    Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
    Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Lee K; Kim H; An K; Kwon OB; Park S; Cha JH; Kim MH; Lee Y; Kim JH; Cho K; Kim HS
    Sci Rep; 2016 Oct; 6():34433. PubMed ID: 27708404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unveiling OSCP as the potential therapeutic target for mitochondrial dysfunction-related diseases.
    Zhang M; Luo X; Zhang B; Luo D; Huang L; Long Q
    Life Sci; 2024 Jan; 336():122293. PubMed ID: 38030056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer's disease.
    Verma H; Gangwar P; Yadav A; Yadav B; Rao R; Kaur S; Kumar P; Dhiman M; Taglialatela G; Mantha AK
    Mitochondrion; 2023 Nov; 73():19-29. PubMed ID: 37708950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.
    Wang Y; Wu L; Li J; Fang D; Zhong C; Chen JX; Yan SS
    J Alzheimers Dis; 2015; 43(2):451-63. PubMed ID: 25096625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
    Calkins MJ; Reddy PH
    Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease.
    Ruiz-Pérez G; Ruiz de Martín Esteban S; Marqués S; Aparicio N; Grande MT; Benito-Cuesta I; Martínez-Relimpio AM; Arnanz MA; Tolón RM; Posada-Ayala M; Cravatt BF; Esteban JA; Romero J; Palenzuela R
    J Neuroinflammation; 2021 Sep; 18(1):223. PubMed ID: 34587978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.
    McManus MJ; Murphy MP; Franklin JL
    J Neurosci; 2011 Nov; 31(44):15703-15. PubMed ID: 22049413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-Dependent Decline in Synaptic Mitochondrial Function Is Exacerbated in Vulnerable Brain Regions of Female 3xTg-AD Mice.
    Espino de la Fuente-Muñoz C; Rosas-Lemus M; Moreno-Castilla P; Bermúdez-Rattoni F; Uribe-Carvajal S; Arias C
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
    J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.